Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-709P is a genomic pseudogene related to the active U6 small nuclear RNA (snRNA), an essential component of the spliceosome that catalyzes the excision of introns from pre-mRNA in eukaryotes. The parental U6 snRNA is highly conserved and critical for organism viability; pseudogenes like RNU6-709P arise from duplication or retrotransposition events and accumulate mutations that abrogate their typical function[1][2]. While most pseudogenes, including RNU6-709P, are believed to be nonfunctional relics, recent research suggests that RNA transcripts from some pseudogenes can participate in gene regulation (e.g., as antisense RNAs, small interfering RNAs, or competing endogenous RNAs), but these functions are context-dependent and not established for RNU6-709P specifically[2]. RNU6-709P does not encode a protein, enzyme, transporter, or receptor, and there are no known drugs interacting with it, nor is it used as a biomarker or associated with safety concerns. If structured data is needed for downstream parsing, this entry should be flagged as a pseudogene and not a classic drug target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 709, pseudogene (RNU6-709P).